These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 2760167

  • 1. Resistance to bromocriptine in prolactinomas.
    Pellegrini I, Rasolonjanahary R, Gunz G, Bertrand P, Delivet S, Jedynak CP, Kordon C, Peillon F, Jaquet P, Enjalbert A.
    J Clin Endocrinol Metab; 1989 Sep; 69(3):500-9. PubMed ID: 2760167
    [Abstract] [Full Text] [Related]

  • 2. Effects of the dopamine agonist CV 205-502 in human prolactinomas resistant to bromocriptine.
    Brue T, Pellegrini I, Gunz G, Morange I, Dewailly D, Brownell J, Enjalbert A, Jaquet P.
    J Clin Endocrinol Metab; 1992 Mar; 74(3):577-84. PubMed ID: 1346788
    [Abstract] [Full Text] [Related]

  • 3. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
    Bertherat J, Brue T, Enjalbert A, Gunz G, Rasolonjanahary R, Warnet A, Jaquet P, Epelbaum J.
    J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
    [Abstract] [Full Text] [Related]

  • 4. Perifusion studies of bromocriptine-treated and untreated macroprolactinomas: effects of dopamine, bromocriptine and TRH.
    Bevan JS, Burke CW.
    Clin Endocrinol (Oxf); 1989 Jun; 30(6):667-80. PubMed ID: 2512041
    [Abstract] [Full Text] [Related]

  • 5. Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy.
    Morange I, Barlier A, Pellegrini I, Brue T, Enjalbert A, Jaquet P.
    Eur J Endocrinol; 1996 Oct; 135(4):413-20. PubMed ID: 8921822
    [Abstract] [Full Text] [Related]

  • 6. A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels.
    Barrera CM, Ruiz AE, Banks WA.
    Horm Res; 1991 Oct; 35(3-4):167-9. PubMed ID: 1806471
    [Abstract] [Full Text] [Related]

  • 7. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B, Nesher Y, Barziliai S.
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [Abstract] [Full Text] [Related]

  • 8. The efficacy and tolerability of CV 205-502 (a nonergot dopaminergic drug) in macroprolactinoma patients and in prolactinoma patients intolerant to bromocriptine.
    van der Lely AJ, Brownell J, Lamberts SW.
    J Clin Endocrinol Metab; 1991 May; 72(5):1136-41. PubMed ID: 1673685
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas.
    Tsagarakis S, Tsiganou E, Tzavara I, Nikolou H, Thalassinos N.
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):593-9. PubMed ID: 7634499
    [Abstract] [Full Text] [Related]

  • 10. Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas.
    Caccavelli L, Feron F, Morange I, Rouer E, Benarous R, Dewailly D, Jaquet P, Kordon C, Enjalbert A.
    Neuroendocrinology; 1994 Sep; 60(3):314-22. PubMed ID: 7969790
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E, Camanni F.
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [Abstract] [Full Text] [Related]

  • 12. DNA synthesis by pituitary tumours, with reference to plasma hormone levels and to effects of bromocriptine.
    Lloyd HM, Jacobi JM, Willgoss DA.
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):79-85. PubMed ID: 7641414
    [Abstract] [Full Text] [Related]

  • 13. Dopamine responsiveness of human prolactinoma cells as determined by the reverse hemolytic plaque assay.
    Kojima Y, Arita J, Kuwana N, Kimura F.
    Endocr J; 1995 Jun; 42(3):355-60. PubMed ID: 7670564
    [Abstract] [Full Text] [Related]

  • 14. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A, Pizzocaro A, Liberati D, De Nicolao G, Veldhuis JD, Faglia G.
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [Abstract] [Full Text] [Related]

  • 15. Demonstration of specific dopamine receptors on human pituitary adenomas.
    Koga M, Nakao H, Arao M, Sato B, Noma K, Morimoto Y, Kishimoto S, Mori S, Uozumi T.
    Acta Endocrinol (Copenh); 1987 Apr; 114(4):595-602. PubMed ID: 3577589
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy.
    Popovic V, Simic M, Ilic L, Micic D, Damjanovic S, Djurovic M, Obradovic S, Dieguez C, Casanueva F.
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):103-8. PubMed ID: 9509075
    [Abstract] [Full Text] [Related]

  • 17. Prolactinomas and resistance to dopamine agonists.
    Brue T, Pellegrini I, Priou A, Morange I, Jaquet P.
    Horm Res; 1992 Jan; 38(1-2):84-9. PubMed ID: 1306523
    [Abstract] [Full Text] [Related]

  • 18. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.
    Jaquet P, Hassoun J, Delori P, Gunz G, Grisoli F, Weintraub BD.
    J Clin Endocrinol Metab; 1984 Nov; 59(5):817-24. PubMed ID: 6480809
    [Abstract] [Full Text] [Related]

  • 19. Interferon-alpha-2a is a potent inhibitor of hormone secretion by cultured human pituitary adenomas.
    Hofland LJ, de Herder WW, Waaijers M, Zuijderwijk J, Uitterlinden P, van Koetsveld PM, Lamberts SW.
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3336-43. PubMed ID: 10487708
    [Abstract] [Full Text] [Related]

  • 20. Effect of the new dopaminergic agonist CV 205-502 on plasma prolactin levels and tumour size in bromocriptine-resistant prolactinomas.
    Duranteau L, Chanson P, Lavoinne A, Horlait S, Lubetzki J, Kuhn JM.
    Clin Endocrinol (Oxf); 1991 Jan; 34(1):25-9. PubMed ID: 1672268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.